Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Kaufman, Gabriel N ^a   Zaouter, Charlotte ^a   Valteau, Barthélémy ^a   Sirois, Pierre ^b   Moldovan, Florina ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b IPS Thérapeutique ^*  (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; R 954; UNCLASSIFIED DRUG; AC ORN (OIC2, ALPHA MEPHE5, D BETANAL7, ILE8)DESARG9 BRADYKININ; AC-ORN-(OIC2, ALPHA-MEPHE5, D-BETANAL7, ILE8)DESARG9-BRADYKININ; BRADYKININ; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; DRUG DERIVATIVE; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT INJURY; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; JOINT; MALE; MORPHOLOGY; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PAIN THRESHOLD; RADIOLOGY; RAT; RECEPTOR BLOCKING; WEIGHT BEARING; X RAY; ANIMAL; ANTERIOR CRUCIATE LIGAMENT; ARTHRALGIA; CHRONIC DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; KNEE OSTEOARTHRITIS; LEWIS RAT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ARTHRALGIA; BRADYKININ; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; NOCICEPTION; OSTEOARTHRITIS, KNEE; PEPTIDES, CYCLIC; RATS; RATS, INBRED LEW; RECEPTOR, BRADYKININ B1; WEIGHT-BEARING;

EID: 79955924030     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3338     Document Type: Article

References (61)

1. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007, 213:626-34. 10.1002/jcp.21258, 17786965.
2. Martel-Pelletier J, Lajeunesse D, Pelletier JP. Etiopathogenesis of osteoarthritis. Arthritis and Allied Conditions. A Textbook of Rheumatology 2005, Chap 109:2199-2226. Williams & Wilkins, Koopman WJ, Moreland LW, 15.
3. Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Current opinion in rheumatology 2008, 20:573-80. 10.1097/BOR.0b013e3283103d12, 18698180.
4. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005, 44:7-16.
5. Alcaraz MJ, Megías J, García-Arnandis I, Clérigues V, Guillén MI. New molecular targets for the treatment of osteoarthritis. Biochemical Pharmacology 2010, 80:13-21. 10.1016/j.bcp.2010.02.017, 20206140.
6. Mandelbaum B, Waddell D. Etiology and pathophysiology of osteoarthritis. Orthopedics 2005, 28:S207-214.
7. Khatib AM, Siegfried G, Messai H, Moldovan F, Mitrovic DR. Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes. Cytokine 2002, 17:254-61. 10.1006/cyto.2001.1001, 12027406.
8. Roy-Beaudry M, Martel-Pelletier J, Pelletier JP, M'Barek KN, Christgau S, Shipkolye F, Moldovan F. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction. Arthritis Rheum 2003, 48:2855-64. 10.1002/art.11247, 14558091.
9. Manacu CA, Martel-Pelletier J, Roy-Beaudry M, Pelletier JP, Fernandes JC, Shipkolye FS, Mitrovic DR, Moldovan F. Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production. Arthritis Res Ther 2005, 7:R324-32. 10.1186/ar1489, 1065327, 15743480.
10. Khatib AM, Lomri A, Mitrovic RD, Moldovan F. Articular chondrocyte aging and endothelin-1. Cytokine 2007, 37:6-13. 10.1016/j.cyto.2007.02.005, 17382552.
11. Lodhi KM, Sakaguchi H, Hirose S, Shibabe S, Hagiwara H. Perichondrial localization of ETA receptor in rat tracheal and xiphoid cartilage and in fetal rat epiphysis. Am J Physiol 1995, 268:C496-502.
12. Messai H, Panasyuk A, Khatib A, Barbara A, Mitrovic DR. Endothelin-1 receptors on cultured rat articular chondrocytes: regulation by age, growth factors, and cytokines, and effect on cAMP production. Mech Ageing Dev 2001, 122:519-31. 10.1016/S0047-6374(01)00231-7, 11295169.
13. Khodorova A, Montmayeur JP, Strichartz G. Endothelin receptors and pain. J Pain 2009, 10:4-28. 10.1016/j.jpain.2008.09.009, 2630124, 19111868.
14. De-Melo JD, Tonussi CR, D'Orléans-Juste P, Rae GA. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists. Pain 1998, 77:261-9. 10.1016/S0304-3959(98)00098-0, 9808351.
15. Rossi GP, Sacchetto A, Cesari M, Pessina AC. Interactions between endothelin-1 and the renin-angiotensin-aldosterone system. Cardiovasc Res 1999, 43:300-7. 10.1016/S0008-6363(99)00110-8, 10536660.
16. Shen B, El-Dahr SS. Cross-talk of the renin-angiotensin and kallikrein-kinin systems. Biol Chem 2006, 387:145-50. 10.1515/BC.2006.019, 16497145.
17. Meini S, Maggi CA. Knee osteoarthritis: a role for bradykinin?. Inflamm Res 2008, 57:351-61. 10.1007/s00011-007-7204-1, 18787773.
18. Sainz IM, Uknis AB, Isordia-Salas I, Cadena RAD, Pixley RA, Colman RW. Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis. FASEB J 2004, 18:887-9.
19. Tonussi CR, Ferreira SH. Bradykinin-induced knee joint incapacitation involves bradykinin B2 receptor mediated hyperalgesia and bradykinin B1 receptor-mediated nociception. Eur J Pharmacol 1997, 326:61-5. 10.1016/S0014-2999(97)00153-2, 9178656.
20. Benton HP, Jackson TR, Hanley MR. Identification of a novel inflammatory stimulant of chondrocytes. Early events in cell activation by bradykinin receptors on pig articular chondrocytes. Biochem J 1989, 258:861-7. 1138443, 2499310.
21. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005, 99:6-38. 10.1254/jphs.SRJ05001X, 16177542.
22. Hall JM. Bradykinin receptors. Gen Pharmacol 1997, 28:1-6.
23. Calixto JB, Cabrini DA, Ferreira J, Campos MM. Inflammatory pain: kinins and antagonists. Curr Opin Anaesthesiol 2001, 14:519-26. 10.1097/00001503-200110000-00010, 17019140.
24. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004, 143:803-18. 10.1038/sj.bjp.0706012, 1575942, 15520046.
25. Olfert ED, Cross BM, McWilliam AA, . (Eds) Guide to the Care and Use of Experimental Animals 1993, Ottawa, Ontario: Canadian Council on Animal Care, (Eds).
26. Appleton CTG, McErlain DD, Pitelka V, Schwartz N, Bernier SM, Henry JL, Holdsworth DW, Beier F. Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther 2007, 9:R13. 10.1186/ar2120, 1860072, 17284317.
27. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, Duong LT. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006, 38:234-43. 10.1016/j.bone.2005.08.007, 16185945.
28. Stoop R, Buma P, van der Kraan PM, Hollander AP, Billinghurst RC, Meijers TH, Poole AR, van den Berg WB. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthr Cartil 2001, 9:308-15. 10.1053/joca.2000.0390, 11399094.
29. Williams JM, Felten DL, Peterson RG, O'Connor BL. Effects of surgically induced instability on rat knee articular cartilage. J Anat 1982, 134:103-9. 1167940, 7076535.
30. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992, 50:247-55. 10.1016/0024-3205(92)90331-I, 1310132.
31. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T, Suda H, Yano M. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 1992, 20(Suppl 12):S11-4.
32. Gabra BH, Benrezzak O, Pheng LH, Duta D, Daull P, Sirois P, Nantel F, Battistini B. Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist. J Neuropathol Exp Neurol 2005, 64:782-9. 10.1097/01.jnen.0000178448.79713.5f, 16141788.
33. Neugebauer W, Blais PA, Hallé S, Filteau C, Regoli D, Gobeil F. Kinin B1 receptor antagonists with multi-enzymatic resistance properties. Can J Physiol Pharmacol 2002, 80:287-92. 10.1139/y02-053, 12025963.
34. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr Cartil 2003, 11:821-30. 10.1016/S1063-4584(03)00163-8, 14609535.
35. Bove SE, Laemont KD, Brooker RM, Osborn MN, Sanchez BM, Guzman RE, Hook KE, Juneau PL, Connor JR, Kilgore KS. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthr Cartil 2006, 14:1041-8. 10.1016/j.joca.2006.05.001, 16769229.
36. Vermeirsch H, Biermans R, Salmon PL, Meert TF. Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat. Pharmacol Biochem Behav 2007, 87:349-59. 10.1016/j.pbb.2007.05.010, 17583780.
37. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005, 114:339-46. 10.1016/j.pain.2004.11.008, 15777859.
38. Ware JH. Linear Models for the Analysis of Longitudinal Studies. Am Stat 1985, 39:95-101.
39. Louis TA. General methods for analysing repeated measures. Stat Med 1988, 7:29-45. 10.1002/sim.4780070108, 3281207.
40. R Development Core Team R: A Language and Environment for Statistical Computing 2010, Vienna, Austria: R Foundation for Statistical Computing, R Development Core Team.
41. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 2004, 17:205-16. 10.1007/s10278-004-1014-6, 3046608, 15534753.
42. Clark RL, Cuttino JT, Anderle SK, Cromartie WJ, Schwab JH. Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum 1979, 22:25-35. 10.1002/art.1780220105, 365186.
43. Esser RE, Hildebrand AR, Angelo RA, Watts LM, Murphey MD, Baugh LE. Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. Arthritis Rheum 1995, 38:129-38. 10.1002/art.1780380120, 7818562.
44. Chou MC, Tsai PH, Huang GS, Lee HS, Lee CH, Lin MH, Lin CY, Chung HW. Correlation between the MR T2 value at 4.7 T and relative water content in articular cartilage in experimental osteoarthritis induced by ACL transection. Osteoarthr Cartil 2009, 17:441-7. 10.1016/j.joca.2008.09.009, 18990590.
45. Rosenberg L. Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Jt Surg Amer Vol 1971, 53:69-82.
46. Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.
47. Dray A, Read SJ. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther 2007, 9:212. 10.1186/ar2178, 2206352, 17561993.
48. Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatology 2005, 17:624-8.
49. Blumenkrantz G, Majumdar S. Quantitative magnetic resonance imaging of articular cartilage in osteoarthritis. Eur Cells Mater 2007, 13:76-86.
50. Bolbos RI, Zuo J, Banerjee S, Link TM, Ma CB, Li X, Majumdar S. Relationship between trabecular bone structure and articular cartilage morphology and relaxation times in early OA of the knee joint using parallel MRI at 3 T. Osteoarthr Cartil 2008, 16:1150-9. 10.1016/j.joca.2008.02.018, 2580796, 18387828.
51. Stahl R, Luke A, Li X, Carballido-Gamio J, Ma CB, Majumdar S, Link TM. T1rho, T2 and focal knee cartilage abnormalities in physically active and sedentary healthy subjects versus early OA patients-a 3.0-Tesla MRI study. Eur Radiol 2009, 19:132-43. 10.1007/s00330-008-1107-6, 18709373.
52. Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthr Cartil 2004, 12:263-268. 10.1016/j.joca.2004.01.006, 15023377.
53. Ornetti P, Brandt K, Hellio-Le Graverand MP, Hochberg M, Hunter DJ, Kloppenburg M, Lane N, Maillefert JF, Mazzuca SA, Spector T, Utard-Wlerick G, Vignon E, Dougados M. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthr Cartil 2009, 17:856-863. 10.1016/j.joca.2009.01.007, 19230857.
54. Wang YXJ, Bradley DP, Kuribayashi H, Westwood FR. Some aspects of rat femorotibial joint microanatomy as demonstrated by high-resolution magnetic resonance imaging. Lab Anim 2006, 40:288-95. 10.1258/002367706777611442, 16803646.
55. Wang YX. In vivo magnetic resonance imaging of animal models of knee osteoarthritis. Lab Anim 2008, 42:246-64. 10.1258/la.2007.06041e, 18625580.
56. Muir H. Proteoglycans of cartilage. J Clin Pathol Suppl (R Coll Pathol) 1978, 12:67-81. 1347125, 365895.
57. Roughley PJ. The structure and function of cartilage proteoglycans. Eur Cells Mater 2006, 12:92-101.
58. Qvist P, Bay-Jensen AC, Christiansen C, Dam EB, Pastoureau P, Karsdal MA. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?. Pharmacol Res 2008, 58:1-7. 10.1016/j.phrs.2008.06.001, 18590824.
59. Sanofi-Aventis. Efficacy and Safety Study of Intra-Articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis. 2006-2007. Clinicaltrials.gov Identifier: NCT00303056. , http://clinicaltrials.gov/show/NCT00303056
60. Read SJ, Dray A. Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs 2008, 17:619-40. 10.1517/13543784.17.5.619, 18447590.
61. Song IH, Althoff CE, Hermann KG, Scheel AK, Knetsch T, Burmester GR, Backhaus M. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Annals of the Rheumatic Diseases 2009, 68:75-83.